{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T11:30:24Z","timestamp":1743161424911},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,6]]},"DOI":"10.7759\/cureus.55668","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T20:20:33Z","timestamp":1709756433000},"source":"Crossref","is-referenced-by-count":1,"title":["Acquired von Willebrand Syndrome in a 17-Year-Old With Essential Thrombocythemia: A Case Report With Literature Review"],"prefix":"10.7759","author":[{"given":"Linda","family":"Youn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Kuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirra","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renuka","family":"Maharta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071746","article-title":"Essential thrombocythemia and acquired Von Willebrand syndrome: the Shadowlands between thrombosis and bleeding","volume":"12","author":"Awada H","year":"2020","unstructured":"Awada H, Voso MT, Guglielmelli P, Gurnari C. Essential thrombocythemia and acquired Von Willebrand syndrome: the Shadowlands between thrombosis and bleeding. Cancers (Basel). 2020, 12:1746. 10.3390\/cancers12071746","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"Rumi E","year":"2014","unstructured":"Rumi E, Pietra D, Ferretti V, et al.. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 2014, 123:1544-51. 10.1182\/blood-2013-11-539098","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1679929","article-title":"Fulminant essential thrombocythemia associated with acquired Von Willebrand syndrome and bleeding episodes in a 14-year-old girl","volume":"39","author":"Schneider C","year":"2019","unstructured":"Schneider C, Stutz-Grunder E, L\u00fcer S, et al.. Fulminant essential thrombocythemia associated with acquired Von Willebrand syndrome and bleeding episodes in a 14-year-old girl. Hamostaseologie. 2019, 39:404-8. 10.1055\/s-0039-1679929","journal-title":"Hamostaseologie"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/107602969900500301","article-title":"Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia","volume":"5","author":"Michiels JJ","year":"1999","unstructured":"Michiels JJ. Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia. Clin Appl Thromb Hemost. 1999, 5:147-51. 10.1177\/107602969900500301","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.3211","article-title":"Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients","volume":"125","author":"Mital A","year":"2015","unstructured":"Mital A, Prejzner W, Bieniaszewska M, et al.. Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients. Pol Arch Med Wewn. 2015, 125:914-20. 10.20452\/pamw.3211","journal-title":"Pol Arch Med Wewn"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12967","article-title":"Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count","volume":"13","author":"Lancellotti S","year":"2015","unstructured":"Lancellotti S, Dragani A, Ranalli P, et al.. Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count. J Thromb Haemost. 2015, 13:1226-37. 10.1111\/jth.12967","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1730818","article-title":"Von Willebrand factor multimeric assay in acquired Von Willebrand disease diagnosis: a report of experience from North Estonia Medical Centre","volume":"13","author":"Pikta M","year":"2021","unstructured":"Pikta M, Banys V, Szanto T, et al.. Von Willebrand factor multimeric assay in acquired Von Willebrand disease diagnosis: a report of experience from North Estonia Medical Centre. J Lab Physicians. 2021, 13:195-201. 10.1055\/s-0041-1730818","journal-title":"J Lab Physicians"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16682","article-title":"Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation","volume":"61","author":"Oyedeji O","year":"2021","unstructured":"Oyedeji O, Sheqwara J, Onwubiko I, Lopez-Plaza I, Nagai S, Otrock ZK. Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation. Transfusion. 2021, 61:3277-80. 10.1111\/trf.16682","journal-title":"Transfusion"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.924560","article-title":"Triple-negative essential thrombocythemia complicated by thrombosis and acquired Von Willebrand disease in a young man","volume":"21","author":"Kanderi T","year":"2020","unstructured":"Kanderi T, Puthenpura M, Shrimanker I, Sapna F, Felter SC. Triple-negative essential thrombocythemia complicated by thrombosis and acquired Von Willebrand disease in a young man. Am J Case Rep. 2020, 21:e924560. 10.12659\/AJCR.924560","journal-title":"Am J Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000507883","article-title":"A case of acquired von Willebrand disease secondary to myeloproliferative neoplasm","volume":"13","author":"Sasi S","year":"2020","unstructured":"Sasi S, Yassin MA, Fadul AM. A case of acquired von Willebrand disease secondary to myeloproliferative neoplasm. Case Rep Oncol. 2020, 13:733-7. 10.1159\/000507883","journal-title":"Case Rep Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-014-1707-7","article-title":"Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS)","volume":"101","author":"Rupa-Matysek J","year":"2015","unstructured":"Rupa-Matysek J, Lewandowski K, Lewandowska M, et al.. Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS). Int J Hematol. 2015, 101:405-10. 10.1007\/s12185-014-1707-7","journal-title":"Int J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF01698487","article-title":"Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count","volume":"69","author":"van Genderen PJ","year":"1994","unstructured":"van Genderen PJ, Michiels JJ, van der Poel-van de Luytgaarde SC, van Vliet HH. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count. Ann Hematol. 1994, 69:81-4. 10.1007\/BF01698487","journal-title":"Ann Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.11.011","article-title":"Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera","volume":"41","author":"Rottenstreich A","year":"2017","unstructured":"Rottenstreich A, Kleinstern G, Krichevsky S, et al.. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera. Eur J Intern Med. 2017, 41:49-54. 10.1016\/j.ejim.2016.11.011","journal-title":"Eur J Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25713","article-title":"Platelets from Calreticulin mutated essential thrombocythemia patients are less reactive than JAK2 V617F mutated platelets","volume":"95","author":"Hauschner H","year":"2020","unstructured":"Hauschner H, Bokstad Horev M, Misgav M, Nagar M, Seligsohn U, Rosenberg N, Koren-Michowitz M. Platelets from Calreticulin mutated essential thrombocythemia patients are less reactive than JAK2 V617F mutated platelets. Am J Hematol. 2020, 95:379-86. 10.1002\/ajh.25713","journal-title":"Am J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede A","year":"2011","unstructured":"Tiede A, Rand JH, Budde U, Ganser A, Federici AB. How I treat the acquired von Willebrand syndrome. Blood. 2011, 117:6777-85. 10.1182\/blood-2010-11-297580","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)","volume":"120","author":"Barbui T","year":"2012","unstructured":"Barbui T, Finazzi G, Carobbio A, et al.. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood. 2012, 120:5128-33; quiz 5252. 10.1182\/blood-2012-07-444067","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9124821","article-title":"The essential thrombocythemia, thrombotic risk stratification, and cardiovascular risk factors","volume":"2020","author":"Mancuso S","year":"2020","unstructured":"Mancuso S, Accurso V, Santoro M, et al.. The essential thrombocythemia, thrombotic risk stratification, and cardiovascular risk factors. Adv Hematol. 2020, 2020:9124821. 10.1155\/2020\/9124821","journal-title":"Adv Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini M","year":"2020","unstructured":"Franchini M, Mannucci PM. Acquired von Willebrand syndrome: focused for hematologists. Haematologica. 2020, 105:2032-7. 10.3324\/haematol.2020.255117","journal-title":"Haematologica"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/230871-acquired-von-willebrand-syndrome-in-a-17-year-old-with-essential-thrombocythemia-a-case-report-with-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T20:20:36Z","timestamp":1709756436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/230871-acquired-von-willebrand-syndrome-in-a-17-year-old-with-essential-thrombocythemia-a-case-report-with-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.55668","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,6]]}}}